VC Fund Investments
Oncology player Immuneel Therapeutics raises $15-M led by Eight Roads, True North
Kiran Mazumdar-Shaw co-founded Immuneel Therapeutics, a Bengaluru-based biotech startup that develops cell and gene therapies for cancer, has raised USD 15 million in Series A financing round co-led by Eight Roads Ventures (and its group firm F-Prime Capital) as well as Indian private equity firm, True North. Immuneel Therapeutics is developing a pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular immunotherapies for management and treatment of cancer. The company had previously raised USD 15 million from UHNI, pharma founders and US-based venture capital funds. It will use the new funds to advance its development pipeline and scale.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
